[Current technologies for blood loss prevention during abdominal hysterectomy].
The paper deals with the development and use of original adequate transfusion-infusion programs to compensate for blood loss in abdominal hysterectomies for uterine myomas of varying sizes, by applying the current blood-supplying technologies that permit avoidance of transfusion of donor blood components. Four blood loss-replenishing programs in abdominal hysterectomy for large-sized myomas were studied for impact on the basic functions in premenopasal women. These included: (1) preoperative blood storage of blood autocomponents; (2) normovolemic hemodilution with hydroxyethyl starch (HES) solution being used as a dilutant; (3) administration of HES solutions as an independent solution compensating for blood loss, and (4) intraoperative reinfusion of autoerythrocytes. The proposed transfusion-infusion programs in abdominal hysterectomy for large-sized myomas by applying blood-preserving methods are effective in avoiding the use of donor blood components and accordingly in reducing the frequency of complications associated with transfusions of donor blood components, and improving the postoperative period.
Fedorova
T A
TA
Ragimov
A A
AA
Bogomazova
I V
IV
Rogachevskiĭ
O V
OV
Dzhabrailova
D A
DA
D016913:Blood Component Transfusion / Q000379:methods*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D001793:Blood Preservation; D001804:Blood Transfusion, Autologous / Q000379:methods*; D005260:Female; D006438:Hemodilution / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000627:therapeutic use; D007044:Hysterectomy; D007889:Leiomyoma / Q000601:surgery*; D008875:Middle Aged; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000601:surgery*
D006895:Hydroxyethyl Starch Derivatives